Clear Harbor Asset Management, LLC Kymera Therapeutics, Inc. Transaction History
Clear Harbor Asset Management, LLC
- $1.23 Billion
- Q4 2024
A detailed history of Clear Harbor Asset Management, LLC transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Clear Harbor Asset Management, LLC holds 10,000 shares of KYMR stock, worth $402,900. This represents 0.03% of its overall portfolio holdings.
Number of Shares
10,000
Previous 10,000
-0.0%
Holding current value
$402,900
Previous $473,000
15.01%
% of portfolio
0.03%
Previous 0.04%
Shares
1 transactions
Others Institutions Holding KYMR
# of Institutions
184Shares Held
64.4MCall Options Held
50.6KPut Options Held
81.7K-
Price T Rowe Associates Inc Baltimore, MD6.65MShares$268 Million0.04% of portfolio
-
Baker Bros. Advisors LP New York, NY6MShares$242 Million3.04% of portfolio
-
Bvf Inc San Francisco, CA5.16MShares$208 Million7.77% of portfolio
-
Atlas Venture Life Science Advisors, LLC4.9MShares$197 Million28.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.75MShares$192 Million0.0% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $2.2B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...